Literature DB >> 18784941

The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population.

Yingyu Ma1, Liang Wu, Cuiping Liu, Liqian Xu, Dongmei Li, Ji-Cheng Li.   

Abstract

PURPOSE: This project explored the influence of loss of heterozygosity (LOH) and microsatellite instability (MSI) of locus D8S277 to PINX1 expression of gastric cancer in Chinese people.
METHODS: LOH and MSI of locus D8S277 in 90 paraffin-embedded gastric carcinoma specimens were detected by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). Envision immunohistochemistry was used to assess the expression of PINX1.
RESULTS: The frequency of LOH was higher in cases with lymph node metastasis than those without (18.57 vs. 0.00%, P < 0.01), and was higher in the specimens that were at TNM stage III + IV than those at stage I + II (21.43 vs. 2.94%, P < 0.01). In terms of the frequency of MSI, it was lower in cases with lymph node metastasis than those without (10.00 vs. 30.00%,P < 0.05). The positive rate of PINX1 protein was higher in samples without lymph node metastasis than those with lymph node metastasis (80.00 vs. 50.00%, P < 0.01); and was higher in the cases at TNM stage I + II than those at stage III + IV; and was lower in the cases between 40 and 60 years old than those above 60 years old (43.75 vs. 65.52%, P < 0.05).
CONCLUSION: LOH and MSI of PINX1 may play major role in tumor development and regulate it through different pathways. Because LOH plays a major role in negative expression of PINX1, it can be regarded as a sign of gastric cancer development and MSI may affect the prognosis and tumor turnover.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784941     DOI: 10.1007/s00432-008-0471-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Histopathological identification of colon cancer with microsatellite instability.

Authors:  J Alexander; T Watanabe; T T Wu; A Rashid; S Li; S R Hamilton
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Beta-catenin expression is altered in human colonic aberrant crypt foci.

Authors:  X P Hao; T G Pretlow; J S Rao; T P Pretlow
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

3.  Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.

Authors:  W Yasui; H Yokozaki; J Fujimoto; K Naka; H Kuniyasu; E Tahara
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

4.  [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].

Authors:  Jin-zhong Pang; Lun-xiu Qin; Ning Ren; Qing-hai Ye; Wei-dong Ying; Yin-kun Liu; Zhao-you Tang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2006-06-27

5.  Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas.

Authors:  Won Sang Park; Jong Heun Lee; Jik Young Park; Seong Whan Jeong; Min Sun Shin; Hong Sug Kim; Sang Kyu Lee; Shi Nae Lee; Sug Hyung Lee; Chul Geun Park; Nam Jin Yoo; Jung Young Lee
Journal:  Cancer Lett       Date:  2002-04-25       Impact factor: 8.679

6.  Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma.

Authors:  C Liao; M Zhao; H Song; K Uchida; K K Yokoyama; T Li
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

7.  Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.

Authors:  M Emi; Y Fujiwara; T Nakajima; E Tsuchiya; H Tsuda; S Hirohashi; Y Maeda; K Tsuruta; M Miyaki; Y Nakamura
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

8.  Mutational analysis of PINX1 in hereditary prostate cancer.

Authors:  Gregory A Hawkins; Bao-Li Chang; S Lilly Zheng; Sarah D Isaacs; Kathleen E Wiley; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; Jianfeng Xu; William B Isaacs
Journal:  Prostate       Date:  2004-09-01       Impact factor: 4.104

9.  Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma.

Authors:  Yuji Akiyama; Chihaya Maesawa; Kei Wada; Kentaro Fujisawa; Tetsuya Itabashi; Yoshinori Noda; Takehisa Honda; Nobuhiro Sato; Kaoru Ishida; Akinori Takagane; Kazuyoshi Saito; Tomoyuki Masuda
Journal:  Oncol Rep       Date:  2004-04       Impact factor: 3.906

10.  Genetic changes and histopathological grades in human hepatocellular carcinomas.

Authors:  M Konishi; R Kikuchi-Yanoshita; K Tanaka; C Sato; K Tsuruta; Y Maeda; M Koike; S Tanaka; Y Nakamura; N Hattori
Journal:  Jpn J Cancer Res       Date:  1993-08
View more
  13 in total

1.  PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway.

Authors:  Hong-bin Wang; Xing-wei Wang; Gang Zhou; Wei-qiang Wang; Yong-gang Sun; Shi-ming Yang; Dian-chun Fang
Journal:  J Gastrointest Surg       Date:  2010-06-11       Impact factor: 3.452

2.  PinX1 inhibits cell proliferation, migration and invasion in glioma cells.

Authors:  Peng-Jin Mei; Yan-Su Chen; Ying Du; Jin Bai; Jun-Nian Zheng
Journal:  Med Oncol       Date:  2015-02-20       Impact factor: 3.064

3.  Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients.

Authors:  Yan-qin Huang; Ying Yuan; Wei-ting Ge; Han-guang Hu; Su-zhan Zhang; Shu Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2010-09       Impact factor: 3.066

4.  PinX1 is up-regulated and associated with poor patients' survival in gliomas.

Authors:  Jin Bai; Yan-Su Chen; Peng-Jin Mei; Qing-Hua Liu; Ying Du; Jun-Nian Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells.

Authors:  Xiao-Fen Lai; Cong-Xiang Shen; Zhong Wen; Yu-Hong Qian; Chao-Sheng Yu; Jun-Qi Wang; Ping-Neng Zhong; Hai-Li Wang
Journal:  J Exp Clin Cancer Res       Date:  2012-02-08

6.  PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.

Authors:  Hai-Long Li; Li Han; Hai-Rong Chen; Fei Meng; Qing-Hua Liu; Zhen-Qiang Pan; Jin Bai; Jun-Nian Zheng
Journal:  Oncotarget       Date:  2015-08-28

7.  PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.

Authors:  Meilin Shi; Menghan Cao; Jun Song; Qinghua Liu; Hailong Li; Fei Meng; Zhenqiang Pan; Jin Bai; Junnian Zheng
Journal:  Mol Cancer       Date:  2015-03-26       Impact factor: 27.401

8.  The role of PinX1 in growth control of breast cancer cells and its potential molecular mechanism by mRNA and lncRNA expression profiles screening.

Authors:  Rong Shi; Jue-Yu Zhou; Hui Zhou; Zhen Zhao; Sang-Hua Liang; Wen-Ling Zheng; Wen-Li Ma
Journal:  Biomed Res Int       Date:  2014-02-03       Impact factor: 3.411

9.  Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer.

Authors:  Rong Shi; Zhen Zhao; Hui Zhou; Min Wei; Wen-Li Ma; Jue-Yu Zhou; Wan-Long Tan
Journal:  Cancer Cell Int       Date:  2014-06-06       Impact factor: 5.722

10.  PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.

Authors:  Jian-Ye Liu; Dong Qian; Li-Ru He; Yong-Hong Li; Yi-Ji Liao; Shi-Juan Mai; Xiao-Peng Tian; Yan-Hui Liu; Jia-Xing Zhang; Hsiang-Fu Kung; Yi-Xin Zeng; Fang-Jian Zhou; Dan Xie
Journal:  Mol Cancer       Date:  2013-11-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.